Regimen Monograph: Updated Dose modifications section
Regimen Monograph: Modified Dosage in hepatic impairment, Adverse effects, Drug administration, Pregnancy/lactation and Monitoring sections
Regimen Monograph: Modified Dosage in hepatic impairment, Adverse effects, Drug administration, Pregnancy/lactation and Monitoring sections
Regimen Monograph: Modified Dosage in hepatic impairment, Adverse effects, Drug administration, Pregnancy/lactation and Monitoring sections
Drug Monograph: Modified Indications, Dosage in hepatic impairment, Administration guidelines and Special precautions, and Monitoring sections
Patient Info Sheet EN: Updated/revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Regimen Monograph: Added darolutamide funding information
Regimen Monograph: Updated Premedication and Supportive Measures section
Regimen Monograph: Updated Administration section
Regimen Monograph: new ST-QBP regimen
Regimen Monograph: Updated Rationale and Uses, Cycle Frequency, and Antiemetic Regimen information; added NDFP form
Drug Monograph: Modified Emetogenic potential section; added NDFP form
Regimen Monograph: Updated Antiemetic Regimen information